Amelioration of endotoxin-induced uveitis treated with an IκB kinase β inhibitor in rats

Molecular Vision

Volumn 18, Issue , 2012, Pages 2586-2597

  Lennikov, Anton ^a   Kitaichi, Nobuyoshi ^a,b   Noda, Kousuke ^a   Ando, Ryo ^a   Dong, Zhenyu ^a   Fukuhara, Junichi ^a   Kinoshita, Satoshi ^a   Namba, Kenichi ^a   Mizutani, Miho ^c   Fujikawa, Tomoyuki ^c   Itai, Akiko ^c   Ohno, Shigeaki ^a   Ishida, Susumu ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HEALTH SCIENCES UNIVERSITY OF HOKKAIDO   (Japan)

^c Institute of Medicinal Molecular Design (IMMD) Inc   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIINFLAMMATORY AGENT; I KAPPA B ALPHA ANTIBODY; I KAPPA B KINASE BETA; IMD 0354; IMD 1041; MONOCYTE CHEMOTACTIC PROTEIN 1; N (3,5 BIS TRIFLUOROMETHYLPHENYL) 5 CHLORO 2 HYDROXYBENZAMIDE; NF KAPPA B ANTIBODY; PRODRUG; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CELL COUNT; CELL INFILTRATION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; RAT; UVEITIS;

ADMINISTRATION, ORAL; ANIMALS; AQUEOUS HUMOR; BENZAMIDES; CHEMOKINE CCL2; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTOXINS; GENE EXPRESSION; I-KAPPA B KINASE; INJECTIONS, INTRAPERITONEAL; MALE; NEUTROPHIL INFILTRATION; NF-KAPPA B; PHOSPHORYLATION; PRODRUGS; PROTEIN KINASE INHIBITORS; RATS; RATS, INBRED LEW; TUMOR NECROSIS FACTOR-ALPHA; UVEITIS;

EID: 84869209807     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Rosenbaum JT, McDevitt HO, Guss RB, Egbert PR. Endo-toxin-induced uveitis in rats as a model for human disease. Nature 1980; 286:611-613. [PMID: 7402339].
2. de Vos AF, van Haren MA, Verhagen C, Hoekzema R, Kijl-stra A. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat. Invest Ophthalmol Vis Sci 1994; 35:1100-1106. [PMID: 8125720].
3. Planck SR, Huang XN, Robertson JE, Rosenbaum JT. Cyto-kine mRNA levels in rat ocular tissues after systemic endo-toxin treatment. Invest Ophthalmol Vis Sci 1994; 35:924-930. [PMID: 8125755].
4. Jacquemin E, de Kozak Y, Thillaye B, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in the eye from endotoxin-induced uveitis rats. Invest Ophthalmol Vis Sci 1996; 37:1187-1196. [PMID: 8631633].
5. Bellot JL, Palmero M, Garcia-Cabanes C, Espi R, Hariton C, Orts A. Additive effect of nitric oxide and prostaglandin-E2 synthesis inhibitors in endotoxin-induced uveitis in the rabbit. Inflamm Res 1996; 45:203-208. [PMID: 8741011].
6. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12:141-179. [PMID: 8011280].
7. Zandi E, Chen Y, Karin M. Direct phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science 1998; 281:1360-1363. [PMID: 9 72110 3].
8. Yamaoka S, Courtois G, Bessia C, Whiteside ST, Weil R, Agou F, Kirk HE, Kay RJ, Israel A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell 1998; 93:1231-1240. [PMID: 9657155].
9. Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, Kanamaru A, Akira S. IKK-i, a novel lipo-polysaccharide-inducible kinase that is related to IkappaB kinases. Int Immunol 1999; 11:1357-1362. [PMID: 10 421793].
10. Uota S, Zahidunnabi Dewan M, Saitoh Y, Muto S, Itai A, Utsunomiya A, Watanabe T, Yamamoto N, Yamaoka S. An IkappaB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells. Cancer Sci 2012; 103:100-106. [PMID: 21951590].
11. Sugita A, Ogawa H, Azuma M, Muto S, Honjo A, Yanagawa H, Nishioka Y, Tani K, Itai A, Sone S. Antiallergic and anti-inflammatory effects of a novel I kappaB kinase beta inhibitor, IMD-0354, in a mouse model of allergic inflammation. Int Arch Allergy Immunol 2009; 148:186-198. [PMID: 18849610].
12. Inayama M, Nishioka Y, Azuma M, Muto S, Aono Y, Makino H, Tani K, Uehara H, Izumi K, Itai A, Sone S. A novel IkappaB kinase-beta inhibitor ameliorates bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med 2006; 173:1016-1022. [PMID: 16456147].
13. Onai Y, Suzuki J, Kakuta T, Maejima Y, Haraguchi G, Fuka-sawa H, Muto S, Itai A, Isobe M. Inhibition of IkappaB phosphorylation in cardiomyocytes attenuates myocardial ischemia/reperfusion injury. Cardiovasc Res 2004; 63:51-59. [PMID: 15194461].
14. Kamon J, Yamauchi T, Muto S, Takekawa S, Ito Y, Hada Y, Ogawa W, Itai A, Kasuga M, Tobe K, Kadowaki T. A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance. Biochem Biophys Res Commun 2004; 323:242-248. [PMID: 15351728].
15. Fukuda S, Horimai C, Harada K, Wakamatsu T, Fukasawa H, Muto S, Itai A, Hayashi M. Aldosterone-induced kidney injury is mediated by NFkappaB activation. Clin Exp Nephrol 2011; 15:41-49. [PMID: 21072674].
16. Wang H, Syrovets T, Kess D, Buchele B, Hainzl H, Lunov O, Weiss JM, Scharffetter-Kochanek K, Simmet T. Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasis. J Immunol 2009; 183:4755-4763. [PMID: 19752240].
17. Barnes PJ. Nuclear factor-kappa B. Int J Biochem Cell Biol 1997; 29:867-870. [PMID: 9 30 4 801].
18. Baldwin AS Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996; 14:649-683. [PMID: 871752 8].
19. Yanai A, Maeda S, Shibata W, Hikiba Y, Sakamoto K, Nakagawa H, Ohmae T, Hirata Y, Ogura K, Muto S, Itai A, Omata M. Activation of IkappaB kinase and NF-kappaB is essential for Helicobacter pylori-induced chronic gastritis in Mongolian gerbils. Infect Immun 2008; 76:781-787. [PMID: 18070894].
20. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal tran-scription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-1071. [PMID: 9091804].
21. Gu L, Tseng SC, Rollins BJ. Monocyte chemoattractant protein-1. Chem Immunol 1999; 72:7-29. [PMID: 10550927].
22. Verma MJ, Lloyd A, Rager H, Strieter R, Kunkel S, Taub D, Wakefield D. Chemokines in acute anterior uveitis. Curr Eye Res 1997; 16:1202-1208. [PMID: 9426952].
23. Ueda A, Okuda K, Ohno S, Shirai A, Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y, Okubo T. NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153:2052-2063. [PMID: 8 0 51410].
24. Wang Y, Rangan GK, Goodwin B, Tay YC, Harris DC. Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent. Kidney Int 2000; 57:2011-2022. [PMID: 10792620].
25. Iwata D, Kitaichi N, Miyazaki A, Iwabuchi K, Yoshida K, Namba K, Ozaki M, Ohno S, Umezawa K, Yamashita K, Todo S, Ishida S, Onoe K. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice. Invest Ophthalmol Vis Sci 2010; 51:2077-2084. [PMID: 19907030].
26. Kitamei H, Iwabuchi K, Namba K, Yoshida K, Yanagawa Y, Kitaichi N, Kitamura M, Ohno S, Onoe K. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate. J Leukoc Biol 2006; 79:1193-1201. [PMID: 16 5747 70].